PNC Financial Services Group’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4761 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4438 |
|
|
2022
Q2 | – | Sell |
-17
| Closed | – | – | 4473 |
|
|
2022
Q1 | $0 | Buy |
+17
| New | +$345 | ﹤0.01% | 4512 |
|
|
2020
Q1 | – | Sell |
-4
| Closed | – | – | 3886 |
|
|
2019
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 3978 |
|
|
2019
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 3983 |
|
|
2019
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 4005 |
|
|
2019
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 4020 |
|
|
2018
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 4028 |
|
|
2018
Q3 | $0 | Buy |
+4
| New | +$131 | ﹤0.01% | 4110 |
|
|
2016
Q3 | – | Sell |
-2
| Closed | -$1K | – | 3978 |
|
|
2016
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 4332 |
|
|
2016
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 4343 |
|
|
2015
Q4 | $1K | Sell |
2
-9
| -82% | -$13.8K | ﹤0.01% | 4305 |
|
|
2015
Q3 | $22K | Hold |
11
| – | – | ﹤0.01% | 3318 |
|
|
2015
Q2 | $32K | Buy |
11
+9
| +450% | +$35.9K | ﹤0.01% | 3264 |
|
|
2015
Q1 | $8K | Hold |
2
| – | – | ﹤0.01% | 3848 |
|
|
2014
Q4 | $6K | Sell |
2
-3
| -60% | -$8.46K | ﹤0.01% | 3481 |
|
|
2014
Q3 | $19K | Hold |
5
| – | – | ﹤0.01% | 3066 |
|
|
2014
Q2 | $23K | Hold |
5
| – | – | ﹤0.01% | 2878 |
|
|
2014
Q1 | $24K | Buy |
5
+1
| +25% | +$5.92K | ﹤0.01% | 2789 |
|
|
2013
Q4 | $22K | Buy |
4
+2
| +100% | +$13.2K | ﹤0.01% | 2770 |
|
|
2013
Q3 | $33K | Buy |
+2
| New | +$26.2K | ﹤0.01% | 2646 |
|
Other funds holding ATOS
LCM
SM